Document Information [Line Items]
Document type
Amendment flag
Document period end date
Amendment description
Entity common stock shares outstanding
Entity Listings [Line Items]
Entity Listings, Instrument [Axis]
Instrument [Domain]
Entity Listings [Table]
Entity [Text Block]
Entities [Table]
Entity Information [Line Items]
Entity registrant name
Entity central index key
Current fiscal year end date
Entity well known seasoned issuer
Entity voluntary filers
Entity current reporting status
Entity filer category
Entity public float
Income Statement [Abstract]
Statement [Table]
Statement Scenario [Axis]
Statement [Line Items]
Statement of Financial Position [Abstract]
Statement of Cash Flows [Abstract]
Financial Instruments [Abstract]
Inventories [Abstract]
Goodwill and Other Intangible Assets [Abstract]
Earnings Per Share Attributable To Common Shareholders [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest [Abstract]
Costs and expenses:
Revenues Abstract
Cost of Sales
Restructuring charges and certain acquisition - related costs
Other Income Expense Net
Selling, informational and administrative expenses
Research and development expenses
Amortization of intangible assets
Less: Net income attributable to noncontrolling interests
Net income attributable to Pfizer Inc.
Net income
Discontinued operations - net of tax, total
Income from continuing operations
Provision for taxes on income
Earnings Per Share [Abstract]
Earnings per common share - diluted
Earnings per common share - basic
Weighted-average shares - diluted (in shares)
Weighted-average shares - basic (in shares)
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
Discontinued operations - net of tax (in dollars per share)
EPS Basic
Net income attributable to Pfizer Inc. common shareholders [Diluted]
Discontinued operations - net of tax [Diluted]
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)
Comprehensive Income (Expense) [Text Block]
Inventory Disclosure [Text Block]
Goodwill and Other Intangible Assets [Text Block]
Pension and Postretirement Benefit Plans [Text Block]
Earnings Per Share Attributable to Common Shareholders [Text Block]
Segment, Geographic and Revenue Information [Text Block]
Assets
Liabilities and Shareholders' Equity
Total liabilities and shareholders' equity
Liabilities [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Total assets
Total liabilities
Inventories
Short-term loans
Accounts receivable, less allowance for doubtful accounts: 2010-$217; 2009-$176
Short-term investments
Cash and cash equivalents
Total current assets
Long-term investments and loans
Property, plant and equipment, less accumulated depreciation
Goodwill
Total identifiable intangible assets, less accumulated amortization
Short-term borrowings, including current portion of long-term debt: 2010-$3,502; 2009-$27
Accounts payable
Dividends payable
Income taxes payable
Accrued compensation and related items
Total current liabilities
Long-term debt
Pension benefit obligations
Postretirement benefit obligations
Noncurrent deferred tax liabilities
Other noncurrent liabilities
Total Pfizer Inc shareholders' equity
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2010-8,876; 2009-8,869
Additional paid-in capital
Employee benefit trust, at fair value
Treasury stock, shares at cost; 2010-864; 2009-799
Retained earnings
Accumulated other comprehensive (loss)/income
Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2010-1,279; 2009-1,511
Equity attributable to noncontrolling interests
Total shareholders' equity
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Revenues
This element represents (i) the total amount of other operating income, not previously categorized, from items that are associated with the entity's normal revenue producing operation; and (ii) recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales, as well as excludes research and development expenses and selling, informational and administrative expenses.
Income from continuing operations before provision for taxes on income
Assets held for sale
Acquisition of Wyeth [Text Block]
Financial Instruments Disclosure [Text Block]
Income taxes
Interest
Supplemental Cash Flow Information
Net decrease in cash and cash equivalents
Operating Activities
Investing Activities
Financing Activities
Adjustments To Reconcile Net Income Loss Before Allocation To Noncontrolling Interests To Net Cash Provided By Used In Operating Activities Abstract
Share-based compensation expense
Depreciation and amortization
Deferred taxes from continuing operations
Other non-cash adjustments
Net cash provided by operating activities
Purchases of property, plant and equipment
Purchases of short-term investments
Purchases of long-term investments
Other investing activities
Net cash used in investing activities
Proceeds From Issuances Of Short Term Debt Net Of Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year) and may include the cash inflow from a borrowing having initial term of repayment within three months net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.
Proceeds from issuances of long-term debt
Principal payments on long-term debt
Cash dividends paid
Net cash (used in)/provided by financing activities
Effect of exchange-rate changes on cash and cash equivalents
Income from continuing operations attributable to Pfizer Inc. common shareholders [Dilluted]
Discontinued operations - net of tax (in dollars per share)
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
Treasury stock, shares at cost; 2010-864; 2009-799
Accumulated other comprehensive expense
Purchases of property, plant and equipment
Purchases of short-term investments with original maturities greater than 90 days
Purchases of long-term investments
Other investing activities
Increase in short-term borrowings, net
Principal payments on long-term debt
Cash dividends paid
Other taxes payable
Repayments Of Short Term Debt Maturing In More Than Three Months Net Of Repayments Of Short Term Debt Maturing In Three Months Or Less
Principal payments on short-term borrowings - net
The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year) and may include the cash outflow from a repayment of a borrowing having initial term of repayment within three months net of the cash inflow of a borrowing having initial term of repayment within three months.
Proceeds From Sale And Maturity Of Long Term Marketable Securities
Discontinued operations - net of tax
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of long-term marketable securities (trading, held-to-maturity, or available-for-sale) during the period.
This element represents the complete disclosure related to financial instruments, which may include i) selected financial assets and liabilities; ii) investments in debt and equity securities; iii) short-term borrowings; iv) long-term debt; v) derivative financial instruments and hedging activities; vi) credit risk; and vii) other disclosures related to financial instruments.
This element represents (i) restructuring charges, which are amounts charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and materially changes either the scope of a business undertaken by an entity, or the manner in which that business is conducted; and (ii) acquisition-related costs, which are costs incurred to effect a business combination which costs have been expensed during the period. Such costs can include transaction costs such as banking, legal, accounting and other costs directly related to effect a business combination as well as external, incremental costs of integration planning that are directly related to a business combination, including costs associated with preparing for systems and other integration activities.
Income from continuing operations before provision for taxes on income
Income from continuing operations
Net income before allocation to noncontrolling interests
Net income attributable to Pfizer Inc.
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)
Total current assets
Total assets
Total current liabilities
Total liabilities
Total Pfizer Inc. shareholders' equity
Total shareholders' equity
Total liabilities and shareholders' equity
Net cash provided by operating activities
Net cash used in investing activities
Net cash (used in)/provided by financing activities
Employee benefit trusts
Other financing activities
Document fiscal year focus
Document fiscal period focus
Document Information [Table]
Legal Entity [Axis]
Entity [Domain]
Parent Company [Member]
Restructuring charges and certain acquisition-related costs
Current Deferred Tax Assets And Other Assets Current
This element represents (i) carrying amount as of the balance sheet date of payments made in advance for income and other taxes, which will be charged against earnings within one year or the normal operating cycle, if longer as well as the current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value; and (ii) aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet.
Taxes and other current assets
Non Current Deferred Tax Assets And Other Assets Noncurrent
This element represents (i)the noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference; and (ii) the aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
Taxes and other noncurrent assets
Proceeds from redemptions and sales of long-term investments
Other current liabilities
This element represents (i) the current portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A current taxable temporary difference is a difference between the tax basis and the carrying amount of a current asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference; and (ii) the aggregate carrying amount, as of the balance sheet date, of current obligations not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer).
Acquisition of Wyeth [Abstract]
Cost Reduction Initiatives and Acquisition Related Costs [Abstract]
Cost Reduction Initiatives And Acquisition Related Costs Disclosure [Text Block]
Cost-Reduction Initiatives and Acquistion-Related Costs [Text Block]
Pension And Postretirement Benefit Plans [Abstract]
Adjustments to reconcile net income before noncontrolling interests to net cash provided by operating activities:
Financial Instruments [Text Block]
Other (income)/deductions-net
Increase in short-term borrowings - net
Other Comprehensive Income/(Loss) [Text Block]
Taxes on Income [Abstract]
Taxes on Income [Text Block]
Net decrease in cash and cash equivalents
Description of cost-reduction initiatives associated with a comprehensive plan to integrate acquired operations, generate cost savings and capture synergies across the company; as well as costs incurred in connection with an acquisition. These costs include (i) restructuring activities, including exit and disposal activities, the major types of costs associated with the plan activities and the accrual balance at the end of the period; (ii) integration costs, which represent external, incremental costs directly related to integrating acquired businesses; (iii) implementation costs, which represent external, incremental costs directly related to implementing cost-reduction initiatives prior to the Wyeth acquisition and primarily include expenditures related to system and process standardization and the expansion of shared services; (iv) additional depreciation-asset restructuring, which represents the impact of changes in the estimated useful lives of assets involved in restructuring actions; and (v) transaction costs, representing external costs incurred in connection with an acquisition.
Schedule Of Recognized Identifiable Assets Acquired And Liabilities Assumed As Part Of Business Combination [Text Block]
Schedule of acquired assets and liabilities assumed as of the acquisition date, including measurement period adjustments.
Schedule of Business Acquisition [Table]
Acquisition Purchase Price
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Working Capital Excluding Inventories
Working capital, excluding inventories
InventoriesAcquisition
Property, plant and equipment
In-process research and development
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed In Process Research And Development
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
Other noncurrent assets
The amount of other noncurrent assets recognized as of the acquisition date.
The amount of in process research and development recognized as of the acquisition date.
The amount of working capital, excluding inventories, recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Benefit Obligations
Benefit obligations
The amount of benefit obligations recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Tax Accounts
Net tax accounts
The amount of net tax accounts recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Liabilities
Other noncurrent liabilities
The amount of other noncurrent liabilities recognized as of the acquisition date.
Total identifiable net assets
Total identifiable net assets
Net assets acquired
Net assets acquired
Less: Amounts attributable to noncontrolling interests
Total consideration transferred
Total consideration transferred
Inventories
Schedule of restructuring charges [Text Block]
Schedule of costs in connection with cost-reduction initiatives and the acquisition of Wyeth.
Cost Reduction Initiatives and Acquisition Related Costs [Table]
Cost reduction initiatives and acquisition costs [Line Items]
Business Combination Acquisition Related Costs Integration Costs
Integration costs
Integration costs represent external, incremental costs directly related to integrating Wyeth and primarily include expenditures for consulting and systems integration.
Additional Depreciation Asset Restructuring
Additional depreciation asset restructuring represents the impact of changes in the estimated useful lives of assets involved in restructuring actions.
Implementation Costs
Implementation costs
Implementation costs represent external, incremental costs directly related to Implementing cost-reduction initiatives prior to Pfizer's acquisition of Wyeth, and primarily include expenditures related to system and process standardization and the expansion of shared services.
Cost Reduction Initiatives And Acquisition Costs
Total costs incurred in connection with Pfizer's cost-reduction initiatives and the acquisition of Wyeth.
Cost Reduction Initiatives and Acquisition Costs of Wyeth [Abstract]
Total
Footnote information [Abstract]
Senior unsecured notes
Asset impairments [Member]
Other Restructuring Charges [Member]
Employee termination costs [Member]
Other [Member]
Costs Incurred
Activity
Accrual
Restructuring charges footnote information [Abstract]
Restructuring Charges [Member]
Restructuring charges abstract
Estimated Employee Terminations
Actual Employees Terminated
Business Acquisition [Line Items]
Business Acquisition Purchase Price
Additional depreciation asset restructuring [Member]
Total additional depreciation-asset restructuring
Restructuring and related costs by type [Axis]
Types of restructuring [Domain]
Schedule Of Available For Sale And Held To Maturity Debt Maturities [Text Block]
Contractual maturities of available-for-sale and held-to-maturity debt securities [Text Block]
Schedule of contractual maturities of the available for sale and held to maturity debt securities.
This element represents the disclosure related to certain financial assets and liabilities, including financial assets and liabilities measured at fair value on a recurring basis.
Schedule of gains (losses) on interest rate risk [Text Block]
Financial Instruments [Line Items]
Financial assets measured at fair value on a recurring basis
Financial liabilities measured at fair value on a recurring basis
Available - for - sale debt securities [Member]
Trading securities [Member]
Available - for - sale money market funds [Member]
Available - for - sale equity securities, excluding money market funds [Member]
Foreign currency swaps [Member]
Interest rate swaps [Member]
Foreign currency forward-exchange contracts [Member]
Fair Value Assets Measured on Recurring Basis [Domain]
Fair Value Assets Measured on Recurring Basis Disclosure Items [Axis]
Fair Value Assets Measured on Recurring Basis Disclosure Items [Domain]
Fair Value Liabilities Measured on Recurring Basis Disclosure Items [Axis]
Fair Value Liabilities Measured on Recurring Basis Disclosure Items [Domain]
Other selected financial assets [Abstract]
Other Selected Financial Assets
Total
Other financial liabilities [Abstract]
Other Financial Liabilities
Total
Fair Value Measurements [Table]
Financial Liabilities Measured At Fair Value On Recurring Basis [Abstract]
Footnotes to selected financial assets and liabilities [Abstract]
Money market funds held in escrow
Selected financial assets and liabilities presented in the condensed consolidated balance sheets [Line Items]
Cash and cash equivalents at fair value
Fair value inputs Level 1 [Member]
Selected Financial Liabilities Current Deferred Tax Liabilities And Other Current Liabilities
Other current liabilities
Selected financial liabilities presented in the balance sheet caption, Current deferred tax liabilities and other current liabilities, at the balance sheet date.
Selected Financial Liabilities Other Noncurrent Liabilities
Other noncurrent liabilities
Selected financial liabilities presented in the balance sheet caption, Other Noncurrent liabilities, at the balance sheet date.
Fair Value By Balance Sheet Grouping [Axis]
Fair Value Disclosure Items [Domain]
Investments in Debt and Equity Securities [Abstract]
Debt Securities
This item represents the total of all debt securities grouped by maturity dates.
Total debt securities
Available For Sale Securities Equity Securities Money Market Funds
Available - for - sale money market funds
This item represents equity securities categorized neither as held-to-maturity nor trading. Money market funds represent ownership in debt instruments. If money markets funds are determined to have had an other than temporary decline in fair value below its amortized cost basis the loss loss shall be recognized in earnings.
Available - for - sale securities equity securities excluding money market funds
Available - for - sale equity securities, excluding money market funds
This item represents equity securities excluding money market funds categorized neither as held-to-maturity nor trading. Equity securities excluding money market funds represent ownership interests or the right to acquire ownership interests in corporations and other legal entities which ownership interest is represented by shares of common or preferred stock (which is not mandatorily redeemable or redeemable at the option of the holder), convertible securities, stock rights, or stock warrants. Unrealized gains and losses related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale Security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain or loss of an Available-for-sale Security that is designated as being hedged in a fair value hedge shall be recognized in earnings during the period of the hedge, as should other than temporary declines in fair value below costs basis.
Schedule of available - for - sale securities [Axis]
Major Types of Debt and Equity Securities [Domain]
Securities (Assets) [Member]
Debt Securities [Member]
Western European and other government debt [Member]
Western European and other government agency debt [Member]
Supranational debt [Member]
Represents the debt of international organizations such as the World Bank, the International Monetary Fund, regional multilateral development banks, multilateral financial institutions, and other similar organizations.
Certificates of deposit [Member]
Corporate debt [Member]
Federal Home Loan Mortgage Corporation and Federal National Mortgage Association asset backed securities [Member]
This category includes investments in asset-backed debt securities issued by the Federal Home Loan Mortgage Corporation and Federal National Mortgage Association.
Reverse repurchase agreements [Member]
Schedule of held - to - maturity debt securities [Axis]
Major Types of Debt Securities [Domain]
Certificates of deposit and other [Member]
This category includes information about certificates of deposit and other held to maturity debt securities not separately identified.
Short - Term Borrowings [Abstract]
Commercial paper
Long - Term Debt [Abstract]
Senior unsecured notes at fair value
Derivative Financial Instruments and Hedging Activities
Cash and cash equivalents
Senior unsecured notes
Major Types of Debt Securities [Domain]
Foreign currency debt used as hedging instrument [Member]
Foreign currency borrowings used as hedging instruments [Member]
Available - for - sale debt securities
Held - to - maturity debt securities
Available - for - sale debt securities maturities within 1 year
Available - for - sale debt securities maturities over 1 to 5 years
Available - for - sale debt securities maturities total
Long-term loans, carried at cost
Debt securities maturities over 1 to 5 years
Short-term borrowings, including current portion of long-term debt
Commercial Paper [Member]
Credit Risk
Guarantee [Abstract]
Guarantee for Wyeth's obligation
Collateral received
Schedule Of Components Of Comprehensive Income (Loss) [Text Block]
Schedule of components of comprehensive income (loss).
Net unrealized losses on derivative financial instruments
Net unrealized gains/(losses) on available - for - sale securities
Benefit plan adjustments
Total comprehensive income
Less: Comprehensive income/(loss) attributable to noncontrolling interests
Comprehensive (loss) income attributable to Pfizer Inc.
Total comprehensive income
Comprehensive income attributable to Pfizer Inc.
Schedule Of Components Of Inventories [Text Block]
Total inventories
Finished goods
Work - in - process
Raw materials and supplies
Schedule of changes in carrying amount of goodwill [Text Block]
Goodwill By Segment [Axis]
Goodwill, Segment [Domain]
Biopharmaceutical [Member]
Diversified [Member]
Changes in the carrying amount of goodwill
Balance, beginning
Goodwill Other Adjustments
Reflects net changes to the recorded value of goodwill not separately disclosed, primarily for foreign currency translation adjustments.
Text block covering the Disclosure of the details of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.
Other
Balance, ending
Measurement Period Adjustments Abstract
Measurement Period Adjustment Inventory
Inventories
Measurement Period Adj PPE
Property, plant and equipment
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inprocess Research And Development
In - process research and development
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to net tax accounts in connection with a business combination for which the initial accounting was incomplete.
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to in-process research and development acquired in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Tax Accounts
Net tax accounts
Business Combination Provisional Information Initial Accounting Incomplete Adjustment In Goodwill
Goodwill
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to goodwill acquired in connection with a business combination for which the initial accounting was incomplete.
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed In Goodwill
Goodwill
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
Total identifiable net assets
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
Net assets acquired
Finite-Lived Intangible Assets by Major Class [Axis]
Developed technology rights [Member]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Licensing Agreements [Member]
Trademarks [Member]
Brands [Member]
Finite-lived intangible assets
Finite lived intangible assets gross carrying amount
Gross Carrying Amount
Finite lived intangible assets accumulated amortization
Accumulated Amortization
Finite lived intangible assets net
Identifiable Intangible Assets, less Accumulated Amortization
Other intangible assets [Member]
Other [Member]
Indefinite-lived Intangible Assets By Major Class [Axis]
Indefinite-lived Intangible Assets, Major Class [Domain]
Indefinite-lived intangible assets
Indefinite-lived intangible assets excluding goodwill
Indefinite - lived brands
Indefinite - lived In-process research and development
Indefinite-lived trademarks
Carrying amount as of the balance sheet date for in-process research and development. In-process research and development assets that have not yet received regulatory approval and are required to be classified as indefinite- lived assets until the successful completion or the abandonment of the associated research and development effort. During the development period after acquisition, these assets will not be amortized until approval is obtained.
Carrying amount as of the balance sheet date for brands. Brands represent the amortized or unamortized cost associated with tradenames and know-how, as the products themselves no longer receive patent protection.
The rights acquired through registration of a brand name to gain or protect exclusive use thereof.
Other intangibles not otherwise specified in the taxonomy.
Goodwill and Other Intangible Assets Narrative [Abstract]
Amortization expense for finite-lived intangible assets
Aggregate notional amount of interest rate derivative financial instruments
Derivatibe Instruments, Gain (Loss) by Hedging Relationship [Axis]
Hedging Relationship [Domain]
Fair Value Hedging [Member]
Cash Flow Hedging [Member]
Net Investment Hedging [Member]
Nondesignated [Member]
Gains losses incurred to hedge or offset operational foreign exchange or interest rate risk [Abstract]
Recognized in OID
Recognized in OCI
Reclassified from OCI to OID
Derivative Instruments Gain (Loss) by Derivative Instrument Risk [Axis]
Foreign currency short - term borrowings [Member]
Foreign currency long - term debt [Member]
Derivative Contract Type [Domain]
Non - Derivative Financial Instruments in Net Investment Hedge Relationships [Abstract]
Schedule of net periodic benefit costs of pension and post retirement benefit plans [Text Block]
Financial Instruments Narrative [Abstract]
Posted collateral
Additional collateral
Selected Financial Assets
Selected Financial Liabilities
Financial Assets Measured At Fair Value On Recurring Basis [Abstract]
Segment, Geographic and Revenue Information [Abstract]
Business Acquisition [Table]
United States Supplemental Non Qualified Pension Plans Of U S Entity Defined Benefit [Member]
U.S. Qualified [Member]
International [Member]
U.S. Supplemental (Non-Qualified) [Member]
Defined Benefit Plans Disclosures Defined Benefit Plans [Axis]
Defined Benefit Plans [Domain]
Pension Plans Defined Benefit [Member]
Other Postretirement Benefit Plans Defined Benefit [Member]
Postretirement Plans [Member]
Amortization of: [Abstract]
Service cost
Interest cost
Expected return on plan assets
Prior service costs/(credits)
Curtailments and settlements - net
Net periodic benefit costs
Pension and Postretirement Benefit Plans Narrative [Abstract]
Contributions
Expected contributions in next fiscal year
Special termination benefits
Schedule Of Earnings Per Share Basic By Common Class And Schedule Of Earnings Per Share Diluted By Common Class [Text Block]
Net periodic benefit costs
Total indefinite-lived intangible assets
Income from continuing operations attributable to Pfizer Inc.
Less: Preferred stock dividends - net of tax
Net income attributable to Pfizer Inc. common shareholders
Net income attributable to Pfizer Inc. common shareholders and assumed conversions
Weighted-average number of common shares outstanding - Basic
EPS Numerator - Basic:
EPS Numerator - Diluted:
Common-share equivalents: stock options, stock issuable under employee compensation plans and convertible preferred stock
Weighted-average number of common shares outstanding - Diluted
Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans
Eps Numerator Diluted Abstract
Effective tax rate
Tax benefits for resolution of certain tax positions
Schedule of Segment Reporting Information by Segment [Text Block]
Schedule of Revenue by Products [Text Block]
Revenues SI
Segment Reporting Information by Segment [Axis]
Reporting Segment [Domain]
Corporate / Other [Member]
Segment Revenues and Profit Loss [Abstract]
Segment profit / loss
Segment profit/loss
Purchase Accounting Significant Impacts
Purchase accounting for acquisitions
Significant impacts of purchase accounting for acquisitions, including intangible asset amortization and charges related to fair value adjustments.
Biopharmaceutical consists of the Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets customer-focused units and includes products that prevent and treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye diseases and endocrine disorders, among others. Biopharmaceutical segment profit includes costs related to research and development, manufacturing, and sales and marketing activities that are associated with the products in our Biopharmaceutical segment.
Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, including vaccines, parasiticides and anti-infectives; Consumer Healthcare products that include over-the-counter healthcare products such as pain management therapies (analgesics and heat wraps), cough/cold/allergy remedies, dietary supplements, hemorrhoidal care and personal care items; Nutrition products such as infant and toddler nutritional products; and Capsugel, which represents our capsule products and services business. Diversified segment profit includes costs related to research and development, manufacturing, and sales and marketing activities that are associated with the products in our Diversified segment.
Certain costs, such as significant impacts of purchase accounting for acquisitions, restructuring and acquisition-related costs and costs related to our cost-reduction initiatives.
Net Interest Income Expense
Net interest income
Acquisition Related Costs
Acquisition - related costs
Products [Domain]
Animal Health [Member]
Consumer Healthcare [Member]
Nutrition [Member]
Capsugel [Member]
Lipitor [Member]
Enbrel [Member]
Lyrica [Member]
Effexor [Member]
Celebrex [Member]
Prevnar / Prevenar (7-valent) [Member]
Viagra [Member]
Xalatan / Xalacom [Member]
Norvasc [Member]
Zyvox [Member]
Prevnar / Prevenar 13 [Member]
Zosyn / Tazocin [Member]
Detrol / Detrol LA [Member]
Sutent [Member]
Premarin family [Member]
Geodon / Zeldox [Member]
Genotropin [Member]
Chantix / Champix [Member]
Vfend [Member]
BeneFIX [Member]
Caduet [Member]
Aricept [Member]
Zithromax / Zmax [Member]
ReFacto AF/ Xyntha [Member]
All other [Member]
Alliance revenues [Member]
Aromasin [Member]
Zoloft [Member]
Revatio [Member]
Medrol [Member]
Cardura [Member]
Significant product revenues
Revenues
Revenues by geographic area [Line Items]
Significant product revenues are as follows:
Entity - Wide Disclosure on Geographic Areas, Revenue from External Customers Attributed to Individual Foreign Countries [Axis]
Segment, Geographical [Domain]
Revenue by geographic area - United States
Revenue by geographic area - Foreign Countries
Total Revenues
Net tax accounts
Implementation costs [Member]
Restructuring Accrual [Member]
Intangible assets, gross carrying amount
Expected return on plan assets
Special termination benefits
The gross carrying amount of all identifiable intangible assets for the period ended.
Total selected financial assets at the balance sheet date.
Total selected financial liabilities.
Total selected financial assets
Total selected financial liabilities
Transaction costs representing external costs directly related to a business combination and integration cots representing external, incremental costs directly related to integrating acquired operations.
Amount of net interest income and expense.
Restructuring charges and implementation costs associated with Pfizer's cost-reduction initiatives.
Total debt securities maturities
This item represents debt securities which are expected to mature within one year of the balance sheet date.
This item represents debt securities which are expected to mature after one year and through five years from the balance sheet date.
Total other financial liabilities
Item represents the expected reduction of the workforce due to cost-reduction initiatives.
Item represents the number of employees terminated.
The excess of the consideration transferred for Wyeth over the fair value of acquired net assets recognized as of the acquisition date.
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to the net amount recognized as of the acquisition date for the aggregate identifiable assets acquired in excess of or less than the aggregate liabilities assumed.
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to the net amount recognized as of the acquisition date for the aggregate assets, including goodwill, in excess of or less than the aggregate liabilities assumed. This amount may also be viewed as the measurement period adjustment to the incremental amount of equity that the consolidated entity (including the portion attributable to the noncontrolling interest) will recognize as a result of the business combination.
Less: Amounts attributable to noncontrolling interests
Current deferred tax liabilities and other current liabilities
Other noncurrent liabilities
Cost Reduction Initiatives and Acquisition Costs of Wyeth
Footnote information
Restructuring charges footnote information
Restructuring charges
Current deferred tax liabilities and other current liabilities
Other noncurrent liabilities
Financial Assets Measured At Fair Value On Recurring Basis
Other selected financial assets
Financial Liabilities Measured At Fair Value On Recurring Basis
Other financial liabilities
Footnotes to selected financial assets and liabilities
Selected financial assets and liabilities presented in the condensed consolidated balance sheets
Liabilities
Short - Term Borrowings
Long - Term Debt
Guarantee
Investments in Debt and Equity Securities
Gains / (losses) incurred to hedge or offset operational foreign exchange or interest rate risk
Non - Derivative Financial Instruments in Net Investment Hedge Relationships
Financial Instruments Narrative
Goodwill and Other Intangible Assets Narrative
Restructuring and acquisition - related costs
Amortization of:
Pension and Postretirement Benefit Plans Narrative
Segment Revenues and Profit Loss
Debt securities maturities within 1 year
Goodwill [Line Items]
Revenues
Other comprehensive income, net of tax
Amounts Previously Recognized as of Acquisition Date (provisional) [Member]
Measurement Period Adjustments [Member]
Amounts Recognized as of Acquisition Date, As Adjusted [Domain]
Measurement Period Adjustments
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles Excluding In Process Research And Development
The amount of identifiable intangible assets excluding in process research and development recognized as of the acquisition date.
Identifiable intangible assets, excluding in-process research and development
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Debt
The amount of long term debt recognized as of the acquisition date.
Long-term debt
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Identifiable Intangible Assets Excluding In Process Research And Development
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to identifiable intangible assets excluding in process research and development in connection with a business combination for which the initial accounting was incomplete.
Identifiable intangible assets, excluding in-process research and development
Business Combination Acquisition Related Costs Transaction Costs
This element represents external costs directly related to effecting a business combination which costs have been expensed during the period. Such costs include advisory, legal, accounting, valuation, and other similar services.
Transaction costs
Goodwill Purchase Price Adjustments
Reflects net changes to the recorded value of goodwill not yet allocated to reportable segments for purchase accounting adjustments needed to revise the carrying amount of goodwill to fair value.
Additions
Actuarial losses
Total profit
Total revenues
Actuarial losses
Wyeth [Member]
Business Acquisition [Axis]
Business Acquisition Acquiree [Domain]
Net income attributable to Pfizer Inc. common shareholders EPS
Net income attributable to Pfizer Inc. common shareholders
Revenues
Goodwill [Table]
Schedule of Inventories [Table]
Inventories [Table]
Schedule of Indefinite-lived and Finite-lived Intangible Assets [Table]
Schedule of Defined Benefit Plans Disclosures [Table]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Earnings Per Share Basic and Diluted by Common Class [Table]
Segment Reporting Information [Line Items]
Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Individual Foreign Countries [Table]
Schedule of Available for sale Securities and Held to maturity Securities [Table]
Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]
Schedule of Comprehensive Income (Loss) [Table]
Schedule of Restructuring Charges [Table]
Restructuring Charges [Line Items]
Income Taxes [Line Items]
Income Taxes [Table]
Derivative Instruments Gain (Loss) [Line Items]
Schedule of Available for sale Securities and Held to maturity Securities [Line Items]
Inventories [Line Items]
Schedule of Earnings Per Share Basic and Diluted [Line Items]
Schedule of Comprehensive Income [Line Items]
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Working Capital Excluding Inventories
Working capital, excluding inventories
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to working capital excluding inventories in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Noncurrent Assets
Other noncurrent assets
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to other noncurrent assets in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Long Term Debt
Long-term debt
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to long term debt in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Benefit Obligations
Benefit obligations
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to benefit obligations in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Noncurrent Liabilities
Other noncurrent liabilities
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to other noncurrent liabilities in connection with a business combination for which the initial accounting was incomplete.
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Business Combination Acquisition Of Less Than 100 Percent Noncontrolling Interest Fair Value
Less: Amounts attributable to noncontrolling interests
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to the fair value of the noncontrolling interest in the acquiree at the acquisition date.
Total consideration transferred Measurement Period
Total consideration transferred
Schedule Of Cost Reduction Initiatives And Acquisition Related Costs Text Block
Schedule of costs in connection with cost-reduction initiatives and the Wyeth acquisition [Text Block]
Unused Bridge Loan
Short-Term financing agreement entered into with certain financial institutions to partially fund the acquisition of Wyeth. Pfizer did not incur any borrowings under the bridge term loan credit agreement and it was terminated in June 2009.
Schedule of identifiable intangible assets [Text Block]
Goodwill Acquired During Period
Additions
Selected Financial Assets And Liabilities Text Block
Information about certain financial assets and liabiltiies [Text Block]
Selected Financial Assets And Liabilities By Balance Sheet Grouping [Text Block]
This item represents the locations of selected financial assets and liabilities by balance sheet grouping at the balance sheet date.
Selected financial assets and liabilities presented in the condensed consolidated balance sheets [Text Block]
This item represents investments in debt securities which are categorized neither as held-to-maturity nor trading. Such securities are reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the security is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain or loss of an Available-for-sale Security shall be recognized in earnings during the period of the hedge, for other than temporary declines in fair value below cost basis.
This item represents equity securities categorized neither as held-to-maturity nor trading. Money market funds represent ownership in debt instruments. If money markets funds are determined to have had an other than temporary decline in fair value below its amortized cost basis the loss loss shall be recognized in earnings.
This item represents equity securities excluding money market funds categorized neither as held-to-maturity nor trading. Equity securities excluding money market funds represent ownership interests or the right to acquire ownership interests in corporations and other legal entities which ownership interest is represented by shares of common or preferred stock (which is not mandatorily redeemable or redeemable at the option of the holder), convertible securities, stock rights, or stock warrants. Unrealized gains and losses related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale Security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain or loss of an Available-for-sale Security that is designated as being hedged in a fair value hedge shall be recognized in earnings during the period of the hedge, as should other than temporary declines in fair value below costs basis.
This category includes information about debt securities (such as bonds) issued by political subdivisions.
The carrying value of securities purchased to be resold in reverse repurchase transactions.
Held To Maturity Securities Debt Maturities Net Carrying Amount
Held - to - maturity debt securities, carried at amortized cost
Instruments used as offsets (assets)
Instruments used as offsets (liabilities)
Selected Financial Assets Cash And Cash Equivalents
Cash and cash equivalents
Selected Financial Assets Long Term Investments And Loans
Long-term investments and loans
Selected Financial Assets Current Deferred Tax Assets And Other Current Assets
Taxes and other current assets
Selected Financial Assets Noncurrent Deferred Tax Assets And Other Noncurrent Assets
Taxes and other noncurrent assets
Selected financial assets presented in the balance sheet caption, Cash and cash equivalents, at the balance sheet date.
Selected financial assets presented in the balance sheet caption, Long-term investments and loans, at the balance sheet date.
Selected financial assets presented in the balance sheet caption, Current deferred tax assets and other current assets, at the balance sheet date.
Selected financial assets presented in the balance sheet caption, Noncurrent deferred tax assets and other noncurrent assets, at the balance sheet date.
Other asset backed securities [Member]
Held-to-maturity Securities, Debt Maturities, within One Year, Net Carrying Amount
Held - to - maturity debt securities maturities within 1 year
Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Net Carrying Amount
Held - to - maturity debt securities with maturities over 1 to 5 years
Held - to - maturity debt securities maturities total
Marketable Securities
Total
Aggregate notional amount of foreign currency derivative financial instruments
Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]
Income Statement and Other Comprehensive Income Location [Domain]
Other Comprehensive Income [Member]
Other Income Expense [Member]
US Treasury interest rate locks [Member]
Non Derivative Financial Instruments In Net Investment Hedge Relationships Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
Non Derivative Financial Instruments In Net Investment Hedge Relationships Gain Loss Recognized In Income Net
Recognized in OCI
Recognized in OID
Aggregate fair value of net derivative liabilities
Concentration risk maximum exposure
Securities received as collateral
Total
Total
This category includes information about debt securities (such as bonds) that are issued by a either a domestic or foreign national government.
Asset write-offs and impairment charges
Purchases of common stock
Purchases of common stock
Amounts Recognized as of Acquisition Date (final) [Member]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Domain]
Senior Debt Obligations [Member]
Schedule Of Defined Benefit Plan Net Periodic Benefit Costs Text Block
Schedule Of Defined Benefit Plan Net Periodic Benefit Costs Text Block.
Impairment charge
Goodwill not allocated [Member]
Schedule of Finite Lived And Indefinite Lived Intangible Assets By Major Class Text Block
Schedule Of Earnings Per Share Basic By Common Class And Schedule Of Earnings Per Share Diluted By Common Class Text Block.
Cost reduction initiatives
Restructuring charges and implementation costs
Pristiq [Member]
Developed Europe [Member]
Developed Rest Of World [Member]
Emerging Markets [Member]
Gain (loss) net recorded in income from non-derivative financial instruments in net investment hedge relationships.
Gain (loss) net recorded in other comprehensive income from non-derivative financial instruments in net investment hedge relationships.
Private Equity Securities Owned Carried At Cost Or Equity
Private equity securities, carried at cost or equity method
This item represents the carrying amount on the entity's balance sheet of its investment in private equity securities accounted for under the cost and equity methods. The carrying amount for equity method investees is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment losses recognized. The original cost of the cost method investments may differ from the aggregate carrying amount due to various adjustments such as: (i) dividends received in excess of earnings after the date of investment that are considered a return of investment and therefore recorded as reductions to cost of the investment, or (ii) a series of operating losses of an investee or other factors which may indicate that a decrease in value of the investment has occurred which is other than temporary and should accordingly be recognized.
Fair value of long term foreign currency debt which is used as a hedging instrument.
Fair value of short term foreign currency borrowings which are used as hedging instruments.
Long Term Debt Fair Value
Fair value of long term debt
US Corporate Debt Guaranteed By Federal Deposit Insurance Corporation [Member]
This category includes information about debt securities issued by a domestic corporate business entity, which are guaranteed by the Federal Deposit Insurance Corporation.
Trading Securities Held In Trust
Trading securities
Trading securities consists of securities that are bought and held principally for the purpose of selling them in the near term (thus held for only a short period of time). Generally, trading generally reflects active and frequent buying and selling, and trading securities are generally used with the objective of generating profits on short-term differences in price.
Estimated fair value of long term debt at the balance-sheet date.
Goodwill recognized as of the Acquisition Date (as adjusted)
Allocation of Other Goodwill
Inventories
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
Currency translation adjustment and other
Schedule of Comprehensive Income
Indefinite-lived intangible assets brands
Indefinite-lived intangible assets in-process research and development
Indefinite-lived intangible assets trademarks
Short-term loans, carried at cost
Maturing in 2038 [Member]
Schedule of Revenues and Long - Lived Assets by Geographic Area [Text Block]
Schedule of components of inventories.
Tax benefits for resolution of certain tax positions
Recording of Assets Acquired and Liabilities Assumed [Abstract]
Finite Lived and Indefinite Lived Intangible Assets [Line Items]
Footnotes to selected financial assets [Abstract]
King [Member]
Subsequent Event [Table]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Business Combination [Member]
Acquisition [Member]
Subsequent Events [Line Items]
Protonix [Member]
Employee termination costs
The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, including costs or losses pertaining to an entity newly acquired in a business combination as defined by generally accepted accounting principles and costs associated with one-time termination benefits.
Asset impairments
Other
Additional Depreciation Asset Restructuring Abstract
Additional depreciation-asset restructuring, recorded in our Consolidated Statements of Income as follows:
Business Acquisition Cost Of Acquired Entity Purchase Price Per Share
Acquisition Purchase Price Per Share
The per share amount of the total cost to be paid for the acquired entity.
BMP2 [Member]
Rapamune [Member]
Fragmin [Member]
Tygacil [Member]
Other deductions - net
Other (Income) Deductions - Net [Abstract]
Other (Income)/Deductions-Net [Text Block]
Schedule of Other (Income)/Deductions - Net [Text Block]
Schedule of other income deductions net.
Income Taxes
Other Income Deductions Net [Table]
Other (Income) Deductions - Net [Line Items]
Net loss/(gain) on asset disposals
Legal matters
Asset impairment charges and other charges
Certain asset impairment charges
Other, net
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of intangible assets, other than goodwill, to fair value.
Interest expense
Interest income
Royalty - related income
Legal matters, net
Subsidiaries [Member]
Quigley Company Inc [Member]
Acquisition-related in-process research and development charges
Write-off of inventory
Income from continuing operations attributable to Pfizer Inc.
Eps Denominator Abstract
EPS Denominator:
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
Intangible asset impairments
Income Loss From Continuing Operations Available To Common Stockholders Basic
Income from continuing operations attributable to Pfizer Inc. common shareholders
This element represents the income or loss from continuing operations available to common stockholders which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items and cumulative effects of changes in accounting principles, but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests and preferred stock dividends declared or paid in the period, if any.
Pension And Other Postretirement Benefit Contributions Less Pension And Other Postretirement Benefit Expense
Benefit plan contributions (in excess of)/less than expense
The amount of cash or cash equivalents contributed during the reporting period by the entity to fund its pension plans and its non-pension postretirement benefit plans less the amount of pension and other postretirement benefit costs recognized during the period for defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain or loss on assets, prior service cost or credit, transition asset or obligation, and gain or loss due to settlements or curtailments).
Identifiable intangible assets, less accumulated amortization
Schedule of Comprehensive Income [Table]
Purchase accounting significant impacts Inventory
Purchase accounting fair value adjustment related to inventory write-off
Significant impacts of purchase accounting for acquisitions related to inventory fair value adjustments.
Interest income
Royalty - related income
Net gain on asset disposals
Other, net
Short - term borrowings, carried at historical proceeds, as adjusted
Long-term debt, carried at historical proceeds, as adjusted
Escrow Deposit Reduction
Release of money market funds held in escrow
The reduction or release of designated funds, which are funds furnished to assure payments.
Other Comprehensive Income/(Loss) [Abstract]
Short-term loans
Net interest expense/(income)
Additional Asset Impairment Charges And Other Charges
Additional charge against earnings resulting from the write down of assets from their carrying value to their fair value and other associated charges to intangible assets.
Additional asset impairment charges
Schedule Of Components Of Comprehensive Income [Text Block]
Business Acquisition Cost Of Acquired Entity To Be Purchase Price
The total cost of the acquired entity including the cash to be paid to shareholders of acquired entities, fair value of debt and equity securities to be issued to shareholders of acquired entities, the fair value of the liabilities to be assumed, and direct costs of the acquisition.
Acquisition Purchase Price
Impairment Of Intangible Assets Not Including Goodwill
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of intangible assets, other than goodwill, to fair value.
Intangible Assets Impairment
Significant Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]
Other Significant Transactions And Events Disclosure [Text Block]
Other Significant Transactions and Events [Abstract]
Collaborative Arrangements [Abstract]
Collaborative Arrangements [Text Block]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Text Block]
Equity [Abstract]
Share-Based Payments [Abstract]
Share-Based Payments [Text Block]
Lease Commitments [Abstract]
Lease Commitments [Text Block]
Insurance [Abstract]
Insurance [Text Block]
Legal Proceedings and Contingencies [Abstract]
Legal Proceedings and Contingencies [Text Block]
Schedule Of Amounts And Classifications In Consolidated Statement Of Income Of Payments Between Pfizer And Colloboration Partners [Text Block]
Schedule of amounts and classifications in the consolidated statement of income of payments between Pfizer and collaborative partners.
Schedule Income From Continuing Operations Before Provision For Taxes On Income And Income Attributable To Noncontrolling Interests [Text Block]
Schedule of income from continuing operations before provision for taxes on income, and income attributable to noncontrolling interests.
Schedule Provision For Taxes On Income [Text Block]
Schedule of provision for taxes on income.
Schedule Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Text Block]
Schedule of effective income tax rate from continuing operations tax rate reconciliation.
Schedule Tax Effect Of Major Items Recorded As Deferred Tax Assets And Liabilities [Text Block]
Schedule tax effect of major items recorded as deferred tax assets and liabilities.
Schedule Deferred Taxes Classified In Consolidated Balance Sheet
Schedule of deferred taxes classified in the consolidated balance sheet.
Schedule Reconciliation Of Beginning And Ending Amounts Of Unrecognized Tax Benefits [Text Block]
Reconciliation of the beginning and ending amounts of gross unrecognized tax benefits.
Long term debt schedule [Text Block]
Schedule Of Property Plant And Equipment Major Categories [Text Block]
Schedule of property, plant and equipment gross less accumulated depreciation.
Schedule Of Property Plant and Equipment By Major Categories [Text Block]
Income from continuing operations before provision for taxes on income, and income attributable to noncontrolling interests [Text Block]
Provision for taxes on income [Text Block]
Reconciliation of the U.S. statutory income tax rate to the effective tax rate for income from continuing operations [Text Block]
Tax effect of the major items recorded as deferred tax assets and liabilities, shown before jurisdictional netting [Text Block]
Deferred Taxes classified in our Consolidated Balance Sheet [Text Block]
Reconciliation of the beginning and ending amounts of gross unrecognized tax benefits [Text Block]
Schedule of annual intangible asset amortization.
Schedule Of Defined Benefit Plan Amounts That Will Be Amortized From Accumulated Other Comprehensice Income Expense In Next Fiscal Year [Text Block]
Schedule of amounts that will be amortized from accumulated other comprehensive income/(expense) in the next fiscal year.
Schedule of accumulated other comprehensive income/(expense) expected to be amortized into net periodic benefit costs [Text Block]
Schedule Of Defined Benefit Plan Weighted Average Assumptions Used In Calculating Benefit Obligation And Net Periodic Benefit Cost [Text Block]
Schedule of weighted average assumptions used in calculating benefit obligation and net periodic benefit cost.
Schedule of weighted-average actuarial assumptions [Text Block]
Schedule of healthcare cost trend rate assumptions [Text Block]
Schedule Of Defined Benefit Plan Effect Of One Percentage Point Change In Assumed Health Care Cost Trend Rates [Text Block]
Schedule of defined benefit plan effect of one percentage point change in assumed health care cost trend rates.
Schedule of the effect of a one-percentage-point increase or decrease in the health care cost trend rate assumed for postretirement benefits [Text Block]
Schedule Of Defined Benefit Plan Change In Benefit Obligations Plan Assets And Funded Status [Text Block]
Schedule of changes in benefit obligations, plan assets and funded status.
Analysis of the changes in the benefit obligations, plan assets and accounting funded status of pension and postretirement benefit plans [Text Block]
Schedule Of Defined Benefit Plan Amounts Recognized In Consolidated Balance Sheet [Text Block]
Schedule of amounts recognized in consolidated balance sheet [Text Block]
Schedule Of Defined Benefit Plan Amounts Recognized In Accumulated Other Comprehensive Income Expense [Text Block]
Schedule of amounts recognized in accumulated other comprehensive income/(expense) associated with the defined benefit plan.
Schedule of amounts recognized in accumulated other comprehensive income/(expense) [Text Block]
Schedule Of Defined Benefit Plan Domestic And International Pension Plan Information [Text Block]
Schedule of domestic and international pension plan information.
Information related to the U.S. qualified, U.S. supplemental (non-qualified) and international pension plans [Text Block]
Scheduel Of Defined Benefit Plan Assets [Text Block]
Schedule of plan assets for pension plans and postretirement plans.
Information about plan assets [Text Block]
Schedule Of Defined Benefit Plan Changes By Plan Asset Category [Text Block]
Schedule of changes in Level 3 plan assets by plan asset category.
Schedule of changes in Level 3 plan assets, by plan asset category [Text Block]
Schedule of weighted-average long-term target asset allocations and the percentage of the fair value of plan assets by major investment category [Text Block]
Schedule Of Defined Benefit Plan Expected Future Cash Flow [Text Block]
Schedule of expected future cash flows related to defined benefit plans.
Schedule of expected future cash flow [Text Block]
Performance Share Awards and Performance Contingent Share Awards [Member]
Stock Options [Member]
Restricted Stock Units [Member]
Performance Share Awards [Member]
Total Shareholder Return Units [Member]
Deferred Compensation Share Based Payments [Member]
Parent [Member]
Equity Component [Domain]
Statement Equity Components [Axis]
Share Based Payments [Line Items]
Schedule Of Share Based Compensation Expense And Associated Tax Benefit [Text Block]
Schedule of share based compensation expense and associated tax benefit [Text Block]
Schedule of share based compensation expense and associated tax benefit.
Schedule Of Share Based Compensation Valuation Assumptions [Text Block]
Schedule of share based compensation valuation assumptions.
Schedule of valuation assumptions [Text Block]
Schedule Of Share Based Compensation Activity [Text Block]
Schedule of share based compensation activity.
Schedule of stock option actvity [Text Block]
Schedule Of Share Based Compensation Activity Data [Text Block]
Summary of stock option activity data [Text Block]
Schedule of share based compensation activity data.
Schedule Of Operating Leases Of Leasee [Text Block]
Schedule of operating leases.
Schedule of operating leases [Text Block]
Schedule Of Segment Capital Expenditures And Depreciation [Text Block]
Schedule of capital expenditures and depreciation by segment.
Schedule of segment assets, property, plant and equipment additions, and depreciation amortization [Text Block]
Significant Accounting Policies [Table]
Acquisition of Wyeth in a cash-and-stock transaction, value
Rebates And Discounts Accrual
Accruals for Medicaid rebates, Medicare rebates, performance-based contract rebates and charge-backs.
Advertising expenses
Income Tax Contingency Benefit Recognition Model Percent
Benefit measured by the percent of the amount that is being realized upon settlement.
Measure the benefit likely of being realized upon settlement, percent greater than
Acquisition of King Pharmaceuticals Inc [Abstract]
Acquisition of King Pharmaceuticals, Inc.
Merger agreement to acquire King Pharmaceuticals in cash
Merger agreement to acquire King Pharmaceuticals, per share, without interest
Other Significant Transactions and Events [Table]
Significant Accounting Policies [Line Items]
Teuto [Member]
Biocon [Member]
Pfizer [Member]
GlaxoSmithKline Plc [Member]
ViiV [Member]
Schedule Of Equity Method Investment Equity Method Investee Name [Axis]
Equity Method Investee Name [Domain]
Schering Plough [Member]
Encysive Pharmaceuticals [Member]
Encysive Pharmaceuticals Inc and Serenex Inc [Member]
CovX, Coley Pharmaceutical Group Inc, and other Animal Health [Member]
CovX [Member]
Bextra and other [Member]
Bextra [Member]
Geodon [Member]
Bextra and Celebrex [Member]
Other Significant Transactions and Events [Line Items]
Equity stake acquired, ownership percent
Equity stake acquired, amount invested
Equity Method Investment Option To Acquire Remaining Ownership Percentage
The option to acquire the remaining percentage of ownership not already owned of common stock or equity participation in the investee accounted for under the equity method of accounting.
Option to acquire remaining ownership percent
Strategic global agreement, upfront payments
Amount paid to escrow account
Eligible to receive additional development and regulatory milestone payments of up to
Equity interest in ViiV, Varying
Investment Not Readily Marketable Cash Flow Discount Rate
The cash flow discount rate used for an investment which is not readily marketable.
Investment Not Readily Marketable Terminal Year Growth Rate
The terminal year growth rate used for an investment which is not readily marketable.
Business Acquisition Research And Development In Process
Intangible assets through acquisition of Encysive and Serenex
Pre-tax charge, agreement-in-principle with the U.S. Department of Justice (DOJ) to resolve previously reported investigations regarding past off-label promotional practices concerning Bextra, as well as certain other investigations
Liability paid, agreement-in-principle with the U.S. Department of Justice (DOJ) to resolve previously reported investigations regarding past off-label promotional practices concerning Bextra, as well as certain other investigations
Tax benefit
Litigation charge, state civil consumer protection allegations related to our past promotional practices concerning Geodon
Percentage of claims outstanding
Pre-tax charges, production litigation
Insurance recoveries, Selling, informational and administrative expenses
Collaborative Arrangements [Table]
Collaborative Arrangements [Line Items]
Collaborative Partner [Member]
Revenues - Alliance revenues
Total revenues from collaborative arrangements
Collaborative Arrangements Narrative Information [Abstract]
Narrative information:
Research and development expenses
Upfront payments and milestone payments
Capitalized interest expense
Gross realized losses on sales of available-for-sale securities
Proceeds from the sale of available-for-sale securities
Charges related to the resolution of certain investigations concerning Bextra and various other products
Charges related to our agreements and our agreements-in-principle to resolve certain litigation and claims involving our non-steroidal anti-inflammatory (NSAID) pain medicines
United States
International
Total
Operating Loss Carry forwards By Tax Authority [Axis]
Income from continuing operations before provision for taxes on income, and income attributable to non-controlling interests [Abstract]
Income from continuing operations before provision for taxes on income, and income attributable to non-controlling interests consist of the following:
Provision for taxes on income consists of the following:
Taxes Currently Payable [Abstract]
Federal
State and local
Current income taxes:
Deferred income taxes:
Deferred Federal Income Tax Expense Benefit
Deferred State And Local Income Tax Expense Benefit
Federal
State and local
Income Tax Expense Benefit Domestic Continuing Operations
Total U.S. tax (benefit)/provision
International [Abstact]
Current income taxes
Deferred income taxes
International:
The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to domestic continuing operations.
Income Tax Expense Benefit Non Domestic Continuing Operations
Total international tax provision
The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to non-domestic continuing operations.
Tax Rate Reconciliation Reconciliation of the U.S. statutory income tax rate to our effective tax rate for income from continuing operations follows:
Effective Income Tax Rate Reconciliation Legal Settlement
The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to legal settlements.
Effective Income Tax Rate Reconciliation Acquisition Costs
The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to costs associated with an acquisition.
All other - net
Effective tax rate for income from continuing operations
U.S. statutory income tax rate
Sales of biopharmaceutical companies
Legal settlements
Wyeth acquisition - related costs
Deferred Taxes Deferred taxes arise as a result of basis differentials between financial statement accounting and tax amounts. The tax effect of the major items recorded as deferred tax assets and liabilities, shown before jurisdictional netting, as of December 31 is as follows:
Deferred Tax Asset Temporary Differences Prepaid Deferred Items
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions attributable to prepaid and related deferred items which can only be realized if sufficient taxable income is generated in future periods to enable the deduction to be taken.
Deferred Tax Liabilities Temporary Differences Prepaid Deferred Items
The tax effect as of the balance sheet date of the amount of the estimated future tax effects attributable to prepaid and related deferred items computed in accordance with generally accepted accepted accounting principles.
Prepaid/deferred items - Deferred tax assets
Prepaid/deferred items - Deferred tax liabilities
Deferred Tax Liabilities Temporary Differences Inventory
Inventories - Deferred tax assets
The tax effect as of the balance sheet date of the amount of the estimated future tax effects attributable to inventory related items computed in accordance with generally accepted accepted accounting principles.
Inventories - Deferred tax liabilities
Deferred Tax Assets Temporary Differences Intangibles
Intangibles - Deferred tax assets
Deferred Tax Assets Temporary Differences Property Plant And Equipment
Property, plant and equipment - Deferred tax assets
Property, plant and equipment - Deferred tax liabilities
The sum of the tax effects as of the balance sheet date of the amount of the estimated future tax deductions arising from all employee compensation and benefits costs, which can only be deducted for tax purposes when the actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Employee benefits - Deferred tax liabilities
Deferred Tax Assets Temporary Differences Tax Deferred Expense Reserves And Accruals Restructuring Charges And Other Charges
Deferred Tax Liabilities Temporary Differences Tax Deferred Expense Reserves And Accruals Restructuring Charges And Other Charges
Deferred Tax Assets Temporary Differences Tax Deferred Expense Reserves And Accruals Legal And Product Liability
The amount as of the balance sheet date of the estimated future tax deductions arising from estimates of restructuring reserve costs and other charges, which can only be deducted for tax purposes when restructuring charges and other charges are actually incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Restructurings and other charges - Deferred tax assets
Restructurings and other charges - Deferred tax liabilities
The amount as of the balance sheet date of the estimated future tax effects arising from estimates of restructuring reserve costs and other charges.
Legal and product liability reserves - Deferred tax assets
Deferred Tax Liabilities Temporary Differences Tax Deferred Expense Reserves And Accruals Legal And Product Liability
Legal and product liability reserves - Deferred tax liabilities
Deferred Tax Assets Temporary Differences Operating Loss Carryforwards And Deferred Tax Assets Tax Credit Carryforwards
The sum of the tax effects as of the balance sheet date of the amount of excesses of tax deductions over gross income in a year which cannot be used on the tax returns in the current year but can be carried forward to reduce taxable income or income taxes payable in a future year, for which there must be sufficient tax-basis income to utilize a portion or all of the carryforward amount to realize the deferred tax asset. Also, the tax effect as of the balance sheet date of the amount of future tax deductions arising from all unused tax credit carryforwards which have been reduced by a valuation allowance.
Net operating loss/credit carryforwards - Deferred tax assets
Net operating loss/credit carryforwards - Deferred tax liabilities
Intangibles - Deferred tax liabilities
Deferred Tax Assets Temporary Differences Undistributed Foreign Earnings
Unremitted earnings - Deferred tax assets
Deferred Tax Assets Temporary Differences State And Local Tax Adjustments
Deferred Tax Liabilities Temporary Differences State And Local Tax Adjustments
State and local tax adjustments - Deferred tax assets
State and local tax adjustments - Deferred tax liabilities
All other - Deferred tax assets
All other - Deferred tax liabilities
Subtotal - Deferred tax assets
Subtotal - Deferred tax liabilities
Valuation allowance
Total deferred taxes - Deferred tax assets
Total/Subtotal deferred taxes - Deferred tax liabilities
Classifications In Consolidated Balance Sheet [Abstract]
Classified in our Consolidated Balance Sheet as follows:
Noncurrent:
Current:
Net deferred tax liability
Taxes on income narrative [Abstract]
Taxes on income narrative:
Pharmacia [Member]
Vicuron [Member]
Esperion [Member]
Other [Member]
Unremitted Earnings Tax Liability Not Recognized Amount
A reconciliation of the beginning and ending amounts of gross unrecognized tax benefits is as follows:
Balance, January 1
Unrecognized Tax Benefits Business Acquisition
Unrecognized Tax Benefits
Acquisition of Wyeth
Decreases based on tax positions taken during a prior period
Increases based on tax positions taken during the current period
Decreases based on tax positions taken during the current period
Unrecognized Tax Benefits Impact Of Foreign Exchange
Impact of foreign exchange
Other, net
Balance, December 31
Taxes on Income - Reconciliation of gross unrecognized tax benefits narrative
Taxes on Income - Reconciliation of gross unrecognized tax benefits narrative:
Interest expense related to our unrecognized tax benefits
Gross accrued interest
Taxes on Income - Reconciliation of gross unrecognized tax benefits [Abstract]
Taxes on Income - Reconciliation of gross unrecognized tax benefits [Table]
Taxes on Income - Reconciliation of gross unrecognized tax benefits [Line Items]
Estimated decrease of gross unrecognized tax benefits within the next 12 months
Schedule of Other Comprehensive Income/(Loss) [Line items]
Actuarial Gains / (Losses) [Member]
Prior Service Costs / (Credits) And Other [Member]
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)
NET UNREALIZED GAINS / (LOSSES)
CURRENCY TRANSLATION ADJUSTMENT AND OTHER
DERIVATIVE FINANCIAL INSTRUMENTS
AVAILABLE FOR-SALE SECURITIES
BENEFIT PLANS
ACTUARIAL GAINS / (LOSSES)
PRIOR SERVICE (COSTS)/ CREDITS AND OTHER
Balance
Other Comprehensive Income Unrealized Holding Gain Loss On Derivatives And Securities Arising During Period Before Tax
Unrealized holding gains
Other Comprehensive Income Reclassification Adjustment On Derivatives And Securities Included In Net Income Before Tax
Reclassification adjustments to income
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss And Net Prior Service Cost Credit Arising During Period Before Tax
Actuarial gains/(losses) and other benefit plan items
Other Comprehensive Income Defined Benefit Plans Amortization Of Actuarial Loss And Net Prior Service Cost Credit Recognized In Net Periodic Benefit Cost Before Tax
Amortization of actuarial losses and other benefit plan items
Other Comprehensive Income Defined Benefit Plans Curtailments And Settlements Net Before Tax
Curtailments and settlements - net
Other Comprehensive Income Adjustment Other Before Tax
Other
Income taxes
Balance
Other Comprehensive Income / (Loss) Narrative [Abstract]
Other comprehensive income / (loss) narrative:
Foreign currency translation adjustments attributable to noncontrolling interests
Weighted-average effective interest rate on short-term borrowings outstanding
Line of credit, maximum borrowing capacity
Line Of Credit Facility Current Borrowing Capacity Before Expiration
Line of credit, current borrowing capacity before expiration
Line of credit, remaining borrowing capacity
Line Of Credit Expiring Within One Year [Member]
Line Of Credit Expiring 2013 [Member]
Line Of Credit Facility [Axis]
Line Of Credit Facility Lender [Domain]
Long Term Debt [Member]
Senior unsecured notes:
Senior Unsecured Debt At 4.45 [Member]
Senior Unsecured Debt At 6.20 [Member]
Senior Unsecured Debt At 5.35 [Member]
Senior Unsecured Debt At 4.75 Euro [Member]
Senior Unsecured Debt At 5.75 Euro [Member]
Senior Unsecured Debt At 3.625 Euro [Member]
Senior Unsecured Debt At 7.20 [Member]
Senior Unsecured Debt At 6.50 U.K. Pound [Member]
Senior Unsecured Debt At 5.95 [Member]
Senior Unsecured Debt At 5.50 [Member]
Senior Unsecured Debt At 6.95 [Member]
Senior Unsecured Debt At 4.55 Euro [Member]
Current portion not included above
Debt Instrument Callable Principal Amount Percentage
Debt Instrument Callable US Treasury Rate Margin Percentage
Debt Instrument Callable Government Bond Rate Margin Percentage
Long-term Debt, by Maturity [Abstract]
2012
2013
2014 FI Short and Long
2015 FI Short and Long
After 2015
Furniture, Fixtures, And Other [Member]
Furniture And Fixtures Gross And Property Plant And Equipment Other
Property, plant and equipment - Useful Life [Abstract]
Property, plant, and equipment - useful life:
Property Plant And Equipment By Type [Axis]
Property Plant And Equipment Type [Domain]
Building [Member]
Machinery And Equipment [Member]
Schedule Of Property Plant And Equipment [Table]
Property Plant And Equipment [Line Items]
Land
Buildings
Machinery and equipment
Furniture, fixtures and other
Construction in progress
Less: Accumulated depreciation
Total property, plant and equipment
USEFUL LIVES (YEARS), MINIMUM
USEFUL LIVES (YEARS), MAXIMUM
Goodwill Narrative Footnote Abstract
Goodwill narrative footnote:
The annual amortization expense expected for the years 2011 through 2015 is as follows:
2011
2012
2013 Year
2014
2015 Goodwill and other intangibles
Amounts recognized in Accumulated other comprehensive income/(expense) follow:
Actuarial losses Pension
Prior service (costs)/credits and other
Total
The following table provides the weighted-average actuarial assumptions:
Weighted-average assumptions used to determine benefit obligations:
Weighted-average assumptions used to determine benefit obligations, Discount rate
Weighted-average assumptions used to determine benefit obligations, Rate of compensation increase
Weighted-average assumptions used to determine net periodic benefit cost:
Weighted-average assumptions used to determine net periodic benefit cost, Discount rate
Weighted-average assumptions used to determine net periodic benefit cost, Expected return on plan assets
Weighted-average assumptions used to determine net periodic benefit cost, Rate of compensation increase
The healthcare cost trend rate assumptions for our U.S. postretirement benefit plans are as follows:
Healthcare cost trend rate assumed for next year
Rate to which the cost trend rate is assumed to decline
Year that the rate reaches the ultimate trend rate
Effect on total service and interest cost components, increase
Effect on total service and interest cost components, decrease
Effect on postretirement benefit obligation, increase
Effect on postretirement benefit obligation, decrease
A one-percentage-point increase or decrease in the health-care cost trend rate assumed for post-retirement benefits would have the following effects as of December 31, 2010:
Changes in benefit obligations, plan assets and accounting funded status [Abstract]
The following table presents an analysis of the changes in 2010 and 2009 in the benefit obligations, plan assets and accounting funded status of our U.S. qualified, U.S. supplemental (non-qualified) and international pension plans and our postretirement plans:
Defined Benefit Plan Change In Benefit Obligation [Abstract]
Change in benefit obligation:
Benefit obligation
Benefit obligation at beginning of year
Employee contributions
Plan amendments
Increases/(decreases) arising primarily from changes in actuarial assumptions
Foreign exchange impact
Acquisitions
Curtailments
Settlements
Benefits paid
Benefit obligation at end of year
Defined Benefit Plan Change In Fair Value Of Plan Assets [Abstract]
Change in plan assets:
Fair value of plan assets pension plan assets
Fair value of plan assets at beginning of year
Actual gain/(loss) on plan assets
Company contributions
EXCHANGE RATE CHANGES
Acquisitions
Settlements Pension
Fair value of plan assets at end of year
Funded status (plan assets less than the benefit obligation) at end of year
Amounts recognized in our consolidated balance [Abstract]
Amounts recognized in our consolidated balance sheet follow:
Noncurrent assets
Current liabilities
Noncurrent liabilities
Funded status
Information related to pension plans [Abstract]
Information related to the U.S. qualified, U.S. supplemental (non-qualified) and international pension plans follows:
Pension plans with an accumulated benefit obligation in excess of plan assets:
Fair value of plan assets
Pension plans with a projected benefit obligation in excess of plan assets:
Fair value of plan assets
Defined Benefit Plan Fair Value Of Plan Assets By Measurement [Axis]
Fair Value Plan Asset Measurement [Domain]
Fair Value Inputs Level 2 [Member]
Fair Value Inputs Level 3 [Member]
Information about plan assets [Abstract]
Information about plan assets follows:
Defined Benefit Plan Cash And Cash Equivalents Value
Defined Benefit Plan Equity Securities [Abstract]
Cash and cash equivalents
Equity securities:
Defined Benefit Plan Global Equity Securities
Global equity securities
Defined Benefit Plan Equity Commingled Funds
Equity commingled funds
Defined Benefit Plan Debt Securities [Abstract]
Defined Benefit Plan Fixed Income Commingled Funds
Fixed income commingled funds
Defined Benefit Plan Government Bonds
Government bonds
Defined Benefit Plan Corpate Debt Securities
Corporate debt securities
Debt securities:
Defined Benefit Plan Other Investments [Abstract]
Other investments:
Defined Benefit Plan Private Equity Funds
Private equity funds
Defined Benefit Plan Insurance Contracts
Insurance contracts
Defined Benefit Plan Other Investments
Other
Total
Equity Securities [Member]
Other investments [Member]
Global equity securities [Member]
Equity commingled funds [Member]
Government bonds [Member]
The following table presents an analysis of changes during 2010 in Level 3 plan assets, by plan asset category, for our U.S. qualified pension plans and international pension plans using significant unobservable inputs to measure fair value:
ACTUAL RETURN ON PLAN ASSETS
ASSETS HELD, END OF YEAR
ASSETS SOLD DURING THE PERIOD
PURCHASES, SALES AND SETTLEMENTS, NET
TRANSFER INTO/(OUT OF) LEVEL 3
The following table presents the weighted-average long-term target asset allocations and the percentage of the fair value of plan assets for our U.S. qualified and international pension plans and postretirement plans by major investment category:
Defined Benefit Plan Cash And Cash Equivalents
Defined Benefit Plan Target Allocation Percentage Of Assets Cash And Cash Equivalents
Cash and cash equivalents, percentage of plan assets
Cash and cash equivalents, target allocation percentage
Equity securities, percentage of plan assets
Equity securities, target allocation percentage
Debt securities, percentage of plan assets
Debt securities, target allocation percentage
Real estate and other investments, percentage of plan assets
Real estate and other investments, target allocation percentage
Defined Benefit Plan Target Allocation Percentage Of Assets
Total, percentage of plan assets
Total, percentage of plan assets, target allocation percentage
Expected future cash flow information [Abstract]
The following table presents expected future cash flow information as of December 31, 2010:
Expected benefit payments:
2011 year
2012 Year for expected benefits
2013
2014 Pension and Post-retirement
2015
2016 - 2020
Unfavorable change in projected benefit obligations underfunded in the aggregate
Defined Benefit Plan Accumulated Benefit Obligation Change
Unfavorable change in accumulated benefit obligations (ABO)
Accumulated benefit obligations (ABO)
Defined Benefit Plan Securities Loaned To Other Companies Maintenance Margin
Maintenance margin
Actuarial Losses Recognized In Accumulated Other Comprehensive Income Expense Average Period
Average period actuarial losses are amortized into net periodic pension costs
Recorded charges related to our Defined Contribution plans
Equity [Text Block]
Equity Detail [Abstract]
Equity [Table]
Common Stock [Member]
Preferred Stock [Member]
Employee Stock Ownership Plans [Member]
Equity [Line Items]
Treasury Stock Acquired Repurchase Authorization Value
Employee Stock Ownership Plan Esop Stated Value
Common stock, shares issued in connection to the Wyeth acquisition
Amount of shares authorized in stock purchase plan, value
Total shares repurchased, shares
Common stock purchased, average cost per share
Series A convertible perpetual preferred stock, per share stated value
Series A convertible perpetual preferred stock, common stock shares when converted
Preferred ESOP held preferred shares with a stated value
Share Based Payments [Table]
Stock Plan 2004 [Member]
2004 Stock Plan [Member]
Pharmacia Plan [Member]
Short - Term Incentive Award [Member]
Share Based Payments Narrative
Share-Based Payments Narrative:
The components of share-based compensation expense and the associated tax benefit follow:
Increase (decrease) the number of shares available for grants
Shares available for award
Maximum shares available per individual during the plan period
Expense
Tax benefit for share-based compensation expense
The fair-value-based method for valuing each stock option grant on the grant date uses, for virtually all grants, the Black-Scholes-Merton option-pricing model, which incorporates a number of valuation assumptions noted in the following table, shown at their weighted-average values:
Expected dividend yield
Risk-free interest rate
Expected stock price volatility
Expected term (years)
Stock option activity [Abstract]
The following table summarizes all stock option activity during 2010:
Outstanding shares
Outstanding weighted-average exercise price per share
Granted, shares
Granted, weighted-average exercise price per share
Exercised, shares
Exercised, weighted-average exercise price per share
Forfeited, shares
Forfeited, weighted-average exercise price per share
Canceled, shares
Canceled, weighted-average exercise price per share
Outstanding, December 31, 2009, shares
Outstanding, December 31, 2010, shares
Outstanding, December 31, 2009, weighted-average exercise price per share
Outstanding, December 31, 2010, weighted-average exercise price per share
Vested and expected to vest, December 31, 2010 , shares
Vested and expected to vest, December 31, 2010 , weighted-average exercise price per share
Vested and expected to vest, December 31, 2010, weighted-average remaining contractual term (years)
Vested and expected to vest, December 31, 2010 , aggregate intrinsic value
Exercisable, December 31, 2010, shares
Exercisable, December 31, 2010, weighted-average exercise price per share
Exercisable, December 31, 2010, weighted-average remaining contractual term (years)
Exercisable, December 31, 2010, aggregate intrinsic value
Data related to all stock option activity [Abstract]
The following table provides data related to award activity:
Weighted-average grant date fair value per stock option
Aggregate intrinsic value on exercise
Cash received upon exercise
Tax benefits realized related to exercise
Total compensation cost related to nonvested stock options not yet recognized, pre-tax
Weighted-average period in years over which stock option compensation cost is expected to be recognized
Rsu grant activity [Abstract]
The following table summarizes award activity during 2010:
Nonvested shares
Nonvested, December 31, 2009, shares
Nonvested weighted-average grant date fair value per share
Nonvested, December 31, 2009, weighted-average grant date fair value per share
Granted, shares Share based payments
Granted, weighted-average grant date fair value per share
Vested, shares
Vested, weighted-average grant date fair value per share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Reinvested Dividend Equivalents In Period
Reinvested dividend equivalents, share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Reinvested Dividend Equivalents Weighted Average Grant Date Fair Value
Reinvested dividend equivalents, weighted-average grant date fair value per share
Forfeited, shares Share based payments
Forfeited, weighted-average grant date fair value per share
Nonvested, December 31, 2010, shares
Nonvested, December 31, 2010, weighted-average grant date fair value per share
Data related to all Rsu activity [Abstract]
The following table provides data related to award activity:
Total fair-value-based amount of shares vested
Weighted average assumptions used in the valuation of Psas [Abstract]
Summarizes all Psa and Pcsa activity with shares granted representing the maximum award that could be achieved
The following table summarizes all PSA and PCSA activity during 2010, with the shares granted representing the maximum award that could be achieved:
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Other Increases Decreases In Period
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Other Increases Decreases In Period Weighted Average Grant Date Fair Value
Modifications, shares
Modifications, weighted-average grant date fair value per share
Data related to all Psa and Pcsa activity [Abstract]
The weighted-average assumptions used in the valuation of PSAs are as follows:
The following table provides data related to all PSA and PCSA activity:
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Aggregate Intrinsic Value
Total intrinsic value of vested PSA/PCSA shares
Lease Commitments [Table]
Component Of Other Operating Cost And Expense General [Axis]
Component Of Other Operating Cost And Expense Name [Domain]
Lease Commitments [Line Items]
Lease Narrative [Abstract]
Lease Narrative:
Operating Leases Rent Expense Minimum Rentals Net Of Sublease Revenue
Rental expense, net of sublease income
This table shows future minimum rental commitments under non-cancelable operating leases as of December 31 for the following years:
Year 1 (2011)
Year 2 (2012)
After 5 Years (After 2015)
Year 5 (2015)
Year 4 (2014)
Year 3 (2013)
Wholesaler Customer [Member]
Concentration Risk Type [Domain]
Concentration Risk By Type [Axis]
Sales Revenue Exceeded 500 Million [Member]
Sales Revenue Goods Net [Member]
Accounts Receivable [Member]
Geographic Concentration Risk [Member]
Nsaid Member
NSAID [Member]
Product Or Service [Axis]
Segment information narrative [Abstract]
Segment information narrative:
Concentration Risk Number
Concentration Risk Amount
Impairment Of Research And Development Materials
Asset impairment charges
Segment Assets, Property, Plant and Equipment Additions, and Depreciation and Amortization [Abstract]
Segment Assets, Property, Plant and Equipment Additions, and Depreciation and Amortization - Additional details follow:
Identifiable assets
Property, plant and equipment additions
Depreciation and amortization segment
Goodwill resulting from our acquisition of Wyeth
Intangible asset amortization
Discontinued operations / Held for sale
Long Lived Assets [Abstract]
Long-lived assets
United States
Long-lived assets
Long Lived Assets
Consolidated
Concentration Risk Percentage
Allowance for doubtful accounts
Current portion of long-term debt
Preferred stock, without par value, at stated value (in dollars per share)
Preferred stock, shares authorized
Preferred stock, issued (in shares)
Common stock, par value (in dollars per share)
Common stock, shares authorized
Common stock, issued (in shares)
Treasury stock, shares at cost (in shares)
PREFERRED STOCK
COMMON STOCK
ADD'L PAID-IN CAPITAL
EMPLOYEE BENEFIT TRUSTS
TREASURY STOCK
RETAINED EARNINGS
SHAREHOLDERS' EQUITY
NON-CONTROLLING INTERESTS
Stock Issued During Period Value Employee Benefit Trust Net
Stock Issued During Period Shares Employee Benefit Trust Net
Preferred Stock Conversions And Redemptions Value
Preferred Stock Conversions And Redemptions Shares
Stockholders Equity Other Shares
Balance, beginning (value)
Balance, Beginning (shares)
Balance, beginning (shares)
Comprehensive income:
Cash dividends declared -
Common stock
preferred stock
Stock option transactions (value)
Stock option transactions (shares)
Purchases of common stock (value)
Purchases of common stock (shares)
Employee benefit trust transactions - net (value)
Employee benefit trust transactions - net (shares)
Preferred stock conversions and redemptions (value)
Preferred stock conversions and redemptions (shares)
Other (value)
Other (shares)
Statement Of Stockholders Equity [Abstract]
Acquisition of Wyeth (value)
Acquisition of Wyeth (shares)
noncontrolling interests
Purchase of subsidiary shares from noncontrolling interests
Balance, ending (value)
Balance, ending (shares)
Proceeds from redemptions and sales of short-term investments with original maturities of 90 days or less - net
Proceeds from redemptions and sales of short-term investments with original maturities of 90 days or less - net
Non-cash transactions:
Non-cash transactions - Acquisition of Wyeth, treasury stock issued
Cash Paid During The Period For [Abstract]
Cash paid during the period for:
Proceeds From Sale And Maturity Of Short Term Marketable Securities More Than Ninety Days
Proceeds from redemptions and sales of short-term investments with original maturities greater than 90 days
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of short term marketable securities (trading, held-to-maturity, or available-for-sale) with original maturities of more than 90 days during the period.
Summary of significant accounting policies [Abstract]
Consolidation And Basis Of Accounting Policy [Text Block]
A. Consolidation and Basis of Presentation
Describes an entity's accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. An entity also may describe its accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary. Also includes a description of the basis of accounting used to prepare the financial statements (for example, U.S. Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
New Accountingt Standards Policy [Text Block]
B. New Accounting Standards
Describes an entity's accounting policy regarding new accounting standards.
Use Of Estimates Policy [Text Block]
C. Estimates and Assumptions
Describes an entity's accounting policy regarding the preparation of financial statements in conformity with generally accepted accounting principles requires the use of management estimates. Estimates used in the determination of carrying amounts of assets or liabilities, or in disclosure of gain or loss contingencies should be disclosed if known information available prior to issuance of the financial statements indicates that both of these criteria are met: (1) It is at least reasonably possible that the estimate of the effect on the financial statements of a condition, situation, or set of circumstances that existed at the date of the financial statements will change in the near term (less than one year from the date of issuance) due to one or more future confirming events, and (2) The effect of the change would be material to the financial statements. The disclosure should indicate the nature of the uncertainty and include an indication that it is at least reasonably possible that a change in the estimate will occur in the near term. Disclosure of the factors that cause the estimate to be sensitive to change also is encouraged. Entities also may identify those areas that are subject to significant estimates.
D. Contingencies
E. Acquisitions
Fair Value Policy [Text Block]
F. Fair Value
Describes the entity's accounting policies for measuring certain assets and certain liabilities at fair value.
G. Foreign Currency Translation
H. Revenues
I. Cost of Sales and Inventories
Selling General And Administrative Expenses And Advertising Costs Policy [Text Block]
J. Selling, Informational and Administrative Expenses
Describes the nature of and identifies the significant items comprising an entity's selling, general and administrative (or similar) report caption. Also, describes an entity's accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.
K. Research and Development Expenses and Acquisition-Related In-Process Research and Development Charges
Amortization Of Intangible Assets Depreciation And Certain Long Lived Assets Policy [Text Block]
Describes an entity's accounting policy for goodwill and intangible assets, finite-lived intangible assets and property, plant and equipment. In relation to goodwill and intangible assets, this accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets. In relation to finite-lived intangible assets, this accounting policy also may address: (1) the amortization method used (2) the useful lives of such assets (3) how the entity assesses and measures impairment of such assets. In relation to property, plant and equipment this accounting policy may include the basis of such assets, depreciation methods used and estimated useful lives, the entity's capitalization policy, including its accounting treatment for costs incurred for repairs and maintenance activities, whether such asset balances include capitalized interest and the method by which such is calculated, how disposals of such assets are accounted for and how impairment of such assets is assessed and recognized.
L. Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets
M. Restructuring Charges and Certain Acquisition-Related Costs
Cash And Cash Equivalents And Statement Of Cash Flows Policy [Text Block]
A description of a company's a) cash and cash equivalents accounting policy and b) policy regarding presentation of financial instruments in the cash flow statement. An entity shall disclose its policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value. Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. In addition, cash equivalents include short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.
N. Cash Equivalents and Statement of Cash Flows
O. Investments, Loans and Derivative Financial Instruments
Income Tax Uncertainties Policy [Text Block]
Describes an entity's accounting policy for tax positions taken in the Company's tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of contingencies related to income taxes.
P. Income Tax Contingencies
Pension And Other Postretirement Plans Policy [Text Block]
Describes an entity's accounting policy for its pension and other postretirement benefit plans. This disclosure may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.
Q. Pension and Postretirement Benefit Plans
Share Based Compensation Option And Incentive Plans Policy [Text Block]
R. Share-Based Payments
This element describes an entity's accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
Schedule Of Annual Intangible Asset Amortization [Text Block]
Schedule of annual amortization expense expected [Text Block]
Schedule Of Postretirement Plan Assumed Health Care Cost Trend Rates [Text Block]
Schedule Of Defined Benefit Plan Weighted Average Long Term Target Asset Allocations And Percentage Of Fair Value Of Plan Assets [Text Block]
Schedule of weighted average long term target asset allocations and percentage of fair value of plan assets.
Schedule of revenues and long-lived assets by geographic area.
Strategic Global Agreement Upfront Payments
This element represents the upfront payments made as part of our strategic global agreement.
Amount Paid To Partner Strategic Agreement
Amount paid to partner in strategic agreement
This element represents the amount paid to our partner in the strategic global agreement. This amount was expensed at the time the payment was made.
Strategic Agreement Amount Paid To Escrow Account
This element represents the portion of the strategic agreement deposited in an escrow account which will be released once the terms of the contract are met. The amount is stated as of the reporting date and is included in restricted cash.
Strategic Global Agreement Milestone Eligibility For Additional Payment
The amount the strategic agreement partner can be eligible to receive as an additional investment if certain milestones are met.
Equity Method Investment Ownership Percentage Range Minimum
Represents the minimum ownership percentage range in the investee accounted for under the equity method of accounting.
Equity Method Investment Ownership Percentage Range Maximum
Equity interest in ViiV, Varying
Represents the maximum ownership percentage range in the investee by other equity holder.
Gain Contribution Of Asset
Recognized a gain in connection with the formation of ViiV Healthcare Limited
This item represents a one-time gain recognized as a result of the assets contributed to the investment being less than the investment amount.
Proportionate Share Gain Contribution Of Asset
Pfizer's share of gain with formation
Acquisition-related in-process research and development charges
The acquisition related in-process research and development charges recorded for prior period acquisition.
Business Acquisition Intangible Assets
The amount of identifiable intangible assets recognized in a prior period acquisition.
Number Of States With Civil Claims
Number of states that have civil claims
The number of states that have civil claims against the company.
Payments to states that have adopted compliance measures that complement policies and procedures previously established by Pfizer
Product liability adjustment
The pre-tax adjustment to liabilities for product returns.
Collaborative Arrangement Revenues
Revenues - Revenues
Collaborative Arrangement Alliance Revenues
Revenues earned from partners under co-promotion agreements.
Collaborative Arrangement Total Revenues
Collaborative Arrangement Royalty Expense And Cost Of Sales
Cost of sales
Collaborative Arrangement Selling General And Administrative Expenses
Selling, informational and administrative expenses
Collaborative Arrangement Research And Development Expense
Collaborative Arrangement Upfront And Milestone Payments
Collaborative Arrangement [Axis]
Collaborative Arrangement [Domain]
Gain related to ViiV
Gain Loss Royalty Rights
Sale of certain royalty rights
Gross realized gains on sales of available-for-sale securities
Total provision for taxes on income
Earnings taxed at other than U.S. statutory rate
U.S. research tax credit and manufacturing deduction
Acquired IPR&D
Tax Effect Net Operating Losses
Realization tax effect in net operating losses
Deferred Tax Assets Temporary Differences Employee Benefits
Employee benefits - Deferred tax assets
Deferred Tax Liabilities Temporary Differences Employee Benefits
The sum of the tax effects as of the balance sheet date of the amount of the estimated future tax effects arising from all employee compensation and benefits costs.
Deferred Tax Liabilities Temporary Differences Operating Loss Carryforwards And Deferred Tax Liabilities Tax Credit Carryforwards
Unremitted earnings - Deferred tax liabilities
Deferred Tax Assets Liabilities Current [Abstract]
Deferred Tax Assets Liabilities Noncurrent [Abstract]
Unrecognized Tax Benefits Other
Foreign currency translation adjustments
Actuarial losses related to benefit plan obligations and plan assets and other benefit plan items
Prior service credits related primarily to benefit plan amendments
Lines Of Credit [Member]
Line Of Credit Facility Remaining Borrowing Capacity Amount Lenders Have Committed To Loan Us
Line of credit, remaining borrowing capacity, amount lenders have committed to loan us
Line Of Credit Facility Current Borrowing Capacity Able To Support Commercial Paper Borrowings Before Expiration
Line of credit, current borrowing capacity able to support commercial paper borrowings before expiration
Debt instrument, rate
Financial instruments - Short and long term debt narrative [Abstract]
Financial instruments - Short and long term debt narrative:
Weighted-average life of both our total finite-lived intangible assets and our developed technology rights
Accumulated benefit obligation
Projected benefit obligation
Defined Benefit Plan Real Estate And Defined Benefit Plan Other Investments
Defined Benefit Plan Target Allocation Percentage Of Assets Real Estate And Defined Benefit Plan Target Allocation Percentage Of Assets Other Investments
Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Award Type And Plan Name [Axis]
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Vesting Period
Contractual term
Reduction from Biopharmaceutical in connection with the formation of ViiV
Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
Maximum shares available per individual during the plan period
Impairment associated with certain materials used in our research and development activities that are no longer considered recoverable
Aggregate value of stock issued during the period related to the Employee benefit trust.
Number of stock issued during the period related to the Employee benefit trust.
Aggregate value of preferred stock issued during the period related to conversions and redemptions.
Number of preferred stock issued during the period related to conversions and redemptions.
This element represents share movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
Cash Paid During The Period For [Abstract]
Description of significant transactions and events, including business combinations other than the Wyeth acquisition (or series of individually immaterial business combinations), that occurred during the period.
Schedule of postretirement plan assumed health care cost trend rates.
Schedule of amounts recognized in the consolidated balance sheet associated with the defined benefit plan
Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and discounts to government agencies, wholesalers, distributors and managed care organziations.
This item represents our proportionate share of the gain associated with the indirect retained interest.
The total percent of pending claims outstanding.
Represents sales to our partners of products manufactured by us.
The sum of all revenues from collaborative arrangements.
Cost of sales associated with inventory purchased and royalty expense recorded during the period from transactions with our partners.
Net reimbursements from our partners for selling, informational and administrative expenses incurred.
Net reimbursements, as well as upfront payments and milestone payments earned by our partners.
The cash outflow to our partners for payments made upfront as part of a collaborative arrangement and the payments upon the achievement of milestones.
Abstract
Gains (Losses) of royalty rights during the period.
Abstract
Abstract
The sum of the net operating losses realized during the period.
The cumulative amount of the estimated future tax effects attributable to intangible related items which can only be realized if sufficient taxable income is generated in future periods to enable the deductions to be taken.
The amount as of the balance sheet date of the estimated future tax effects attributable to property, plant and equipment related items which can only be realized if sufficient taxable income is generated in future periods to enable the deduction to be taken.
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from estimates of legal and product liability reserves, which can only be deducted for tax purposes when actual losses are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
The amount as of the balance sheet date of the estimated future tax effects arising from estimates of legal and product liability reserves.
The tax effect as of the balance sheet date of the amount of the estimated future tax effects attributable to net operating losses and credit carryforwards computed in accordance with generally accepted accepted accounting principles.
The amount as of the balance sheet date of the estimated future tax effects attributable to undistributed earnings of subsidiaries and other recognized entities in countries outside the country of domicile which will decrease future taxable income when such earnings are distributed into the country of domicile.
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions attributable to state and local tax adjustment related items which can only be realized if sufficient taxable income is generated in future periods to enable the deduction to be taken.
The amount as of the balance sheet date of the estimated future tax effects attributable to the difference between the state and local tax adjustments in accordance with generally accepted accounting principles.
Abstract
Abstract
Abstract
The amount of earnings from international subsidiaries where a US tax provision has not been made for the period end as these earnings are intended to be permanently reinvested overseas.
The gross amount of increases in unrecognized tax benefits pertaining to uncertain tax positions taken in connection with a business acquisition.
The gross amount of unrecognized tax benefits resulting from foreign exchange.
The net amount of other unrecognized tax benefits including increases based on tax positions taken during a prior period, decreases due to settlments with taxing authorities and decreases as a result of a lapse of applicable statutes of limitations.
Sum of a) Pre tax change in accumulated gains and losses from derivative financial instruments, and b) Gross appreciation or the gross loss in value of the total of unsold available-for-sale securities during the period being reported (except when designated as a fair value hedge).
Sum of pre tax reclassification adjustment for a) accumulated gains and losses from derivative financial instruments, b) Available for sale securities and c) Currency translation adjustments.
Sum of a) Pretax change in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan, that has not been recognized in net periodic benefit cost, and b) The pretax cost (credit) of benefit changes attributable to plan participants' prior service resulting from a plan amendment or plan initiation that occurred during the period. The cost has not yet been recognized in net periodic benefit cost. A plan amendment includes provisions that grant increased (decreased) benefits based on services rendered in prior periods.
Sum of a) Amortization of actuarial loss and other benefit plan items, and b) The net prior service cost or credit recognized in other comprehensive income that is a reclassification adjustment of other comprehensive income as a result of being recognized as a component of net periodic benefit cost for the period.
Sum of pre tax adjustment to other comprehensive income for curtailments and settlements, net, related to defined benefit plans.
Other adjustments to other comprehensive income not otherwise specified in the taxonomy or are not separately reported by the entity.
Amount of current borrowing capacity under the credit facility which can be borrowed before the expiry date.
Amount lenders have committed to loan us out of the borrowing capacity currently available under the credit facility.
Amount of current borrowing capacity under the credit facility able to support commerical paper borrowings before the expiry date.
The rate, based on the principal amount, at which a debt instrument amount can be called.
The margin rate, in addition to the U.S. Treasury rate (benchmark rate), at which a debt instrument amount can be called. The margin rate is the rate charged in addition to the benchmark rate.
The margin rate, in addition to a comparable government bond rate (benchmark rate), at which a debt instrument amount can be called. The margin rate is the rate charged in addition to the benchmark rate.
Abstract
Abstract
For defined benefit pension plans, the change in the actuarial present value of benefits (whether vested or nonvested) attributed by the pension benefit formula to employee service rendered before a specified date and based on employee service and compensation (if applicable) before that date.
For securities loaned to other companies from the US qualified pension plan, the maintenance margin % of the fair value of the collateral relative to the fair value of the loan securities.
The average period over which actuarial losses are recognized in accumulated other comprehensive income or loss.
Cash and cash equivalents included in plan assets in the defined benefit plan.
Abstract
Global equity securities included in plan assets in the defined benefit plan.
Equity commingled funds included in plan assets in the defined benefit plan.
Abstract
Fixed income commingled funds debt securities included in plan assets in the defined benefit plan.
Government bonds debt securities included in plan assets in the defined benefit plan.
Corporate debt securities included in plan assets in the defined benefit plan.
Abstract
Private equity funds included in plan assets in the defined benefit plan.
Insurance contracts included in plan assets in the defined benefit plan.
Other investments that are not otherwise defined in the taxonomy included in plan assets in the defined benefit plan.
The percentage of the fair value of cash and cash equivalents to the fair value of total plan assets held as of the measurement date.
Target allocation percentage of cash and cash equivalents to total plan assets presented on a weighted-average basis as of the measurement date of the latest statement of financial position.
The percentage of the fair value of real estate and other investments to the fair value of total plan assets held as of the measurement date.
Target allocation percentage of investments in real estate and other investments to total plan assets presented on a weighted-average basis as of the measurement date of the latest statement of financial position.
Target allocation percentage of investments to total plan assets presented on a weighted-average basis as of the measurement date of the latest statement of financial position.
Description of share repurchase program and amount authorized by an entity's Board of Directors.
The highest quantity of shares an employee can purchase under the plan per period.
The contractual term of stock option grant.
The number of shares under a share-based award plan other than a stock option plan that represents reinvested dividend equivalents. A dividend reinvestment equivalent allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.
The weighted average fair value as of grant dates pertaining to a share-based award plan other than a stock option plan for reinvested dividend equivalents. A dividend reinvestment equivalent allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.
The number of shares under a share-based award plan other than a stock option plan that were modified during the reporting period.
The weighted average fair value of modifications during the reporting period.
As of the balance sheet date, the total intrinsic value of fully vested equity shares.
This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes net of income from sublease arrangements.
For an entity that discloses a concentration risk in relation to a quantitative amount, this concept represents the number of concentration risks by concentration type.
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration amount by concentration type.
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of certain materials used in research and development activities that are no longer considered recoverable.
Abstract
Amount of long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in total.
Carrying amount at the balance sheet date for long-lived, depreciable asset commonly used in offices and stores. Examples include desks, chairs, and store fixtures. This element also represents capitalized assets classified as property, plant and equipment not otherwise defined in the taxonomy.
United States [Abstract]
Other Comprehensive Income Loss [Abstract]
Other changes recognized in other comprehensive (income)/loss
Defined Benefit Plan Net Periodic Benefit Cost And Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
Total recognized in net periodic benefit costs and other comprehensive (income)/loss
The total amount recognized in net periodic benefit costs and other comprehensive (income)/expense for defined benefit plans for the period.
Gains on disposals
(Gains)/losses on sales of discontinued operations
This item represents the gains on disposals of product lines, property, plant and equipment, investments, intangibles and other assets, none treated as discontinued operations.
Changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable
Inventories CFS
Other assets
Accounts payable and other liabilities
Other tax accounts, net
Acquisitions, net of cash acquired
Liabilities of discontinued operations
Lease commitments [Member]
Schedule Of Segment Reporting Information By Segment [Table]
Accounts receivable
Inventories
Other assets
Gains on sales of discontinued operations
common stock SSE
United States [Member]
2015
2015
2014
2014
Non United States Countries [Member]
Total property, plant and equipment before accumulated depreciation
Class Action Lawsuit [Member]
Loss Contingencies By Nature Of Contingency [Axis]
Loss Contingency Nature [Domain]
Pending Or Threatened Litigation [Member]
Foreign exchange impact
Private Equity Funds [Member]
Share-based payment expense, net of tax
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Average Peer Stock Volatility Rate
The average measure of the percentage amount by which the share price of a a peer company fluctuates during a period.
Average peer stock price volatility
Number Of Employees Terminated [Abstract]
Number Of Employees Terminated:
Trading Days
Subsequent Events [Abstract]
Taxes on Income by type [Axis]
Accounts type [Domain]
Provision for taxes on income [Member]
Gross accrued interest [Member]
Unrecognized tax benefit [Member]
The following table presents the amount in Accumulated other comprehensive income/(expense) expected to be amortized into 2011 net periodic benefit costs:
Total pensions
Prior service credits and other
Actuarial losses
Acquisitions, net of cash acquired
Allocated Share Based Compensation Expense Net Of Tax
The amount of expense, net of income tax, recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
Share-based payment expense, net of tax
Insurance Contracts [Member]
Plan Asset Categories [Domain]
Defined Benefit Plan By Plan Asset Categories [Axis]
Face amount or stated value per share of preferred ESOP; generally not indicative of the fair market value per share.
Net income before allocation to noncontrolling interests
Tax benefit for share-based compensation expense
Expected Benefit Payments Abstract
Fair value of collateral received, amount
Loss Contingency Resolution Pending Claims Percentage
Collaborative Arrangement Other Income Deductions Net
Other deductions - net
Net other income/deductions from transactions with collaborative partners.
Expected employer contributions
Preferred stock, dividend rate percentage
Series A convertible perpetual preferred stock, Dividends rate
The percentage rate used to calculate dividend payments on preferred stock.
Outstanding, December 31, 2010, weighted-average remaining contractual term
Oustanding, December 31, 2010, aggregate intrinsic value
Proceeds From Short Term Loans
Proceeds from redemptions of short-term loans with original maturities greater than 90 days
The cash inflow associated with the redemption of short term loans.
Fair Value of Consideration Transferred Abstract
Fair Value of Consideration Transferred
Acquiree Common Stock Shares Outstanding
Total number of shares of common stock of the entity being acquired which were outstanding at the acquisition date.
Business Combination Exchange Ratio
Exchange ratio used to convert acquiree's common stock outstanding that is canceled to shares of acquirer common stock.
Multiplied by Pfizer's stock price as of the acquisition date multiplied by the exchange ratio of 0.985 ($17.66(a) x 0.985)
Wyeth common stock outstanding as of the acquisition date
Common Stock Price
Pfizer stock price
Price of common stock
Business Combination Merger Consideration Price Per Share
Merger consideration - price per share
Stock component value per share is based on the closing market price of Acquirer's common stock on the acquisition date multipied by the exchange ratio.
Business Combination Cash Consideration Per Common Share Outstanding
Acquiree's common stock outstanding that is canceled and converted to cash value in consideration for the business combination.
Cash consideration per common share
Fair Value of Wyeth common stock calculated using Pfizer stock price
Business Cash Consideration Fair Value
Fair Value of Wyeth common stock multiplied by the merger consideration
The acquisition-date fair value of the cash consideration multiplied by the common shares outstanding.
Business Combination Fair Value Stock Options Cancelled
Fair value of Wyeth stock options canceled for a cash payment